AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 281: R150-R154, 2001;
0363-6119/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ballew, J. R.
Right arrow Articles by Fink, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballew, J. R.
Right arrow Articles by Fink, G. D.
Vol. 281, Issue 1, R150-R154, July 2001

Role of ETA receptors in experimental ANG II-induced hypertension in rats

Jennifer R. Ballew and Gregory D. Fink

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824

The objectives were to determine if ANG II-induced hypertension is maintained by activation of endothelin type A (ETA) receptors by endogenous ET-1 and if this effect is influenced by salt intake. Male rats were maintained on high sodium intake (HS; 6 meq/day) or on normal sodium intake (NS; 2 meq/day). Hypertension was produced by intravenous infusion of ANG II (5 ng/min) for 15 days. Five-day oral dosing with the selective ETA-receptor antagonist ABT-627 (~2 mg · kg-1 · day-1) reduced mean arterial pressure (MAP) to baseline levels in rats on HS receiving ANG II infusion, but it did not affect MAP in normotensive HS controls. In rats on NS, ABT-627 only transiently decreased MAP in rats receiving ANG II and slightly reduced MAP in normotensive controls. ABT-627 produced mild retention of sodium and water in NS rats receiving ANG II, but not in any other group. These results indicate that ET-1 plays a role in ANG II-induced hypertension via activation of ETA receptors and that this role is more prominent in rats on HS.

endothelin; blood pressure; salt


This article has been cited by other articles:


Home page
 HypertensionHome page
G. Fink, M. Li, Y. Lau, J. Osborn, and S. Watts
Chronic Activation of Endothelin B Receptors: New Model of Experimental Hypertension
Hypertension, September 1, 2007; 50(3): 512 - 518.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G.-F. Chen and Z. Sun
Effects of chronic cold exposure on the endothelin system
J Appl Physiol, May 1, 2006; 100(5): 1719 - 1726.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
I. Vaneckova, H. J. Kramer, A. Backer, Z. Vernerova, M. Opocensky, and L. Cervenka
Early Endothelin-A Receptor Blockade Decreases Blood Pressure and Ameliorates End-Organ Damage in Homozygous Ren-2 Rats
Hypertension, October 1, 2005; 46(4): 969 - 974.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. L. Yanes, D. G. Romero, V. E. Cucchiarelli, L. A. Fortepiani, C. E. Gomez-Sanchez, F. Santacruz, and J. F. Reckelhoff
Role of endothelin in mediating postmenopausal hypertension in a rat model
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R229 - R233.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Wang and D. H. Wang
Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1868 - H1874.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. E. Gates, H. Tanaka, W. R. Hiatt, and D. R. Seals
Dietary Sodium Restriction Rapidly Improves Large Elastic Artery Compliance in Older Adults With Systolic Hypertension
Hypertension, July 1, 2004; 44(1): 35 - 41.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. F. Reckelhoff and L. A. Fortepiani
Novel Mechanisms Responsible for Postmenopausal Hypertension
Hypertension, May 1, 2004; 43(5): 918 - 923.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Granger
Endothelin
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. T. Yu
Progression of Chronic Renal Failure
Arch Intern Med, June 23, 2003; 163(12): 1417 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. F. Reckelhoff and J. C. Romero
Role of oxidative stress in angiotensin-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. E. Lohmeier
Neurohumoral regulation of arterial pressure in hemorrhage and heart failure
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R810 - R814.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Sasser, J. S. Pollock, and D. M. Pollock
Renal endothelin in chronic angiotensin II hypertension
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R243 - R248.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Ballew and G. D. Fink
Role of endothelin ETB receptor activation in angiotensin II-induced hypertension: effects of salt intake
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2218 - H2225.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online